# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4753641 | 17 | IC50 | = | 0.035 | uM | ALA4724650 | 7.46 | nM | Homo sapiens | ||
2. | ALA4753641 | 17 | IC50 | = | 5.9 | uM | ALA4724649 | 5.23 | nM | Homo sapiens | ||
3. | ALA4753641 | 17 | Ratio IC50 | = | 170 | ALA4724648 | ||||||
4. | ALA4753641 | 17 | IC50 | = | 1.36 | uM | ALA4724647 | 5.87 | nM | Homo sapiens | ||
5. | ALA4753641 | 17 | Ratio IC50 | = | 39 | ALA4724646 | ||||||
6. | ALA4753641 | 17 | IC50 | > | 20 | uM | ALA4724645 | nM | Homo sapiens | |||
7. | ALA4753641 | 17 | INH | = | 6 | % | ALA4724644 | % | Homo sapiens | |||
8. | ALA4753641 | 17 | INH | > | 80 | % | ALA4724643 | % | Homo sapiens | |||
9. | ALA4753641 | 17 | INH | 0 | ALA4724641 | Active | % | Rattus norvegicus | ||||
10. | ALA4753641 | 17 | Cp | = | 0.96 | uM | ALA4724640 | uM | ||||
11. | ALA4753641 | 17 | Drug uptake | = | 1.08 | uM | ALA4724639 | uM | ||||
12. | ALA4753641 | 17 | INH | = | 8 | % | ALA4724638 | % | Homo sapiens | |||
13. | ALA4753641 | 17 | INH | = | -15 | % | ALA4724637 | % | Homo sapiens | |||
14. | ALA4753641 | 17 | INH | = | -34 | % | ALA4724636 | % | Homo sapiens | |||
15. | ALA4753641 | 17 | t1/2 | = | 24 | min | ALA4724635 | hr | ||||
16. | ALA4753641 | 17 | t1/2 | = | 66 | min | ALA4724634 | hr | ||||
17. | ALA4753641 | 17 | Activity | = | 104 | % | ALA4724633 | % | Homo sapiens | |||
18. | ALA4753641 | 17 | Activity | = | 104 | % | ALA4840133 | % | Homo sapiens | |||
19. | ALA4753641 | 17 | t1/2 | = | 24 | min | ALA4840132 | hr | ||||
20. | ALA4753641 | 17 | t1/2 | = | 66 | min | ALA4840131 | hr |